Clinical Trials Directory

Trials / Completed

CompletedNCT03675919

TeLIPro Health Program - Active With Diabetes

The Telemedical Lifestyle Intervention Program TeLIPro (TeLIPro Health Program - Active With Diabetes)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,163 (actual)
Sponsor
West German Center of Diabetes and Health · Academic / Other
Sex
All
Age
25 Years – 79 Years
Healthy volunteers
Not accepted

Summary

In a randomized-controlled trial the hypothesis should be tested that the Telemedical Lifestyle Intervention Program TeLIPro could significantly improve HbA1c (primary outcome), body weight and composition, cardiovascular risk factors, quality of life, eating behavior, and medication demand (secondary outcomes) in type 2 diabetes mellitus (T2DM) patients.

Detailed description

T2DM patients, assured at the health insurance AOK Rhineland / Hamburg will be randomized into two parallel groups. In addition to routine care both groups will be provided a scale as well as a step counter and access to a secured online portal. The TeLIPro group will additionally got a glucose meter with test stripes fpr self-monitoring of blood glucose and telemedical coaching. Participants of both groups will enter their anthropometric and metabolic data into a database on quarterly basis. In addition, the costs for diabetes-specific treatment, inpatient and outpatient treatment costs and drug costs will be analyzed on the basis of the routine data of the AOK Rhineland / Hamburg. Patient preference for type 2 diabetes intervention will be recorded using Discrete Choice Experiment (DCE) questionnaires at the beginning of the program and at the end of the intervention. As part of the development and validation of the DCE, focus groups are used to determine the DCE attributes. In addition, focus groups should also be used during the data collection in order to obtain additional information on patient preferences by means of qualitative analysis.

Conditions

Interventions

TypeNameDescription
DEVICEScaleself-monitoring of body weight; with automatic data transfer into the personalized and secured online portal
DEVICEStep counterself-monitoring of physical activity; with automatic data transfer into the personalized and secured online portal
DEVICEBlood glucose meter with test stripesself-monitoring of blood glucose; with automatic data transfer into the personalized and secured online portal
OTHERAccess to the online portalself-monitoring of health parameters
OTHERTelemedical coachingregular telephone calls providing information about T2DM, healthy lifestyle, low-carbohydrate diet and physical activity

Timeline

Start date
2018-09-15
Primary completion
2021-09-21
Completion
2022-09-30
First posted
2018-09-18
Last updated
2023-01-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03675919. Inclusion in this directory is not an endorsement.